Contact Us

*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Date you started taking this drug:

Date you stopped taking this drug:

Age of patient when antidepressant(s) prescribed:

What condition was this medication prescribed to treat?

What additional medications were you taking at the time?

Did patient hurt themselves during or after taking the drug?

Did patient become violent during or after taking the drug?

Was suicide attempted?

Was hospitalization or institutionalization required after taking antidepressant(s)?

Did loved one commit suicide?

If patient did attempt or commit suicide, did patient ever attempt suicide previously?

If patient did commit suicide, what was the method of suicide?

Please describe violent or suicidal behavior:

If you ever tried to stop taking Paxil and experienced withdrawal, please describe the withdrawal side effects:

Please further describe side effects:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Many Newborns Affected By Mothers' Use of Anti-Depressants during Pregnancy

Feb 7, 2006 | Newsinferno News Staff

A study published in the journal Archives of Pediatrics and Adolescent Medicine reports that nearly a third of infants born to women taking anti-depressants suggesting that expectant mothers may want to consider limiting the use of these powerful drugs during pregnancy.

Thirty percent of the 60 newborns exposed to selective serotonin reuptake inhibitors (SSRIs) in the womb were found to have withdrawal symptoms. 13% of the infants' symptoms were classified as severe said the study by Dr. Rachel Levinson-Castiel of the Children's Medical Center of Israel, in Petah Tiqwa. (Reuters)

Newborns exhibited symptoms such as high-pitched crying, tremors, gastrointestinal problems and disturbed sleep occurred in infants in the first 48 hours after birth.  As the anti-depressant dosage taken by the mother increased, these symptoms became more pronounced.

After examining the 37 infants exposed in the womb to paroxetine hydrochloride, sold as Paxil by GlaxoSmithKline, researchers found the risk was highest among newborns exposed to 27 mg per day or more. Below 20 mg per day the risk of symptoms disappeared.

According to the study, symptoms usually did not peak until after the first day of life.  The long-term effects, however, are not known. Two of infants who were exposed to the drugs suffered short seizures.

Previous studies into the effects of SSRIs on newborns have found other symptoms such as bluish skin color from lack of oxygen, rapid breathing, feeding difficulties, low blood sugar, and jitteriness.

But as we reported last week, women who are clinically depressed and are prescribed anti-depressants cannot simply count on hormonal changes in pregnancy to relieve their symptoms. Some women, therefore, face a severe catch-22 regarding whether or not to continue taking their medication.

"Because maternal depression during pregnancy also entails a risk to the newborn, the risk-benefit ratio of continuing SSRI treatment should be assessed," Levinson-Castiel wrote in the journal Archives of Pediatrics and Adolescent Medicine. Unfortunately, "the long-term effects of in utero exposure to SSRIs have not been demonstrated clearly," not even for those whose symptoms were severe early on, she wrote. (Reuters)

Both studies recommended that if pregnant women must continue to medicate themselves, that they decrease their drug regimen to a one drug, at the very lowest effective dose.

Related articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo